Why does NAD+ matter more after 40?
By midlife, NAD+ in several tissues is lower, partly because NAD-consuming enzymes such as CD38 rise with age; this is linked to weaker mitochondrial function and vascular aging. Raising NAD+ with nicotinamide riboside (NR) has already been shown to increase NAD+ in middle-aged/older people and to improve aortic stiffness and systolic blood pressure. [1] [2]
- Problem: 40+ → ↓NAD+ → ↓mitochondrial output, ↑inflammation, ↑arterial stiffness.
- Strategy: Give an NAD+ precursor with human data (NR), then protect/support with flavonoids and absorption helpers. [3] [4]
What does the 500 mg nicotinamide riboside actually do?
Human studies that saw the clearest vascular wins often used 1,000 mg/day NR in older adults, but 500 mg/day is in range to raise the NAD metabolome. [1] [2]
Ingredient-by-ingredient overview
Swipe to view more →
| Ingredient | Main purpose | Evidence snapshot | Relevance for 40+ |
|---|---|---|---|
| NR 500 mg | Raise NAD+ | ↑NAD+ and lowered SBP. | Core driver. |
| Vitamin D3 | Immune support | Widely used maintenance dose. | Practical add-on. |
| Quercetin Phytosome | Anti-inflammatory | 5–20× better absorbed. | "Inflammaging" brake. |
Bottom line: For a 40+ user who wants to nudge NAD+ upward, get vascular insurance, and keep inflammation from creeping, this is a coherent, daily, low-friction stack.
